Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.0018
%
−2,34%
Latest
0.0752
High
0.0838
Low
0.075
Volume
44 176
Turnover (SEK)
3 424
Market Value (MSEK)
38,3
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Presentation Stora Aktiedagen Stockholm 2017-11-13

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 7,97 7,97 2024-06-26
    Valcuria Holding AB 3,86 3,86 2024-06-26
    Hans Harvig 1,72 1,72 2024-06-26
    Hans Mandahl 1,51 1,51 2024-06-26
    Benny Bengtsson 1,06 1,06 2024-06-26
    Göran Lennart Rehn 0,99 0,99 2024-06-26
    Hartmut Wiese 0,99 0,99 2024-06-26
    Christian Müller 0,99 0,99 2024-06-26
    Christopher Henberg 0,80 0,80 2024-06-26
    Nicholas Peebo 0,78 0,78 2024-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2024-11-12 Delårsrapport 2024-Q3

    • 2025-02-11 Bokslutskommuniké 2024

    Annual reports, prospectus etc.